Stripe, Anthropic and OpenAI are backing an effort to stop respiratory infections

The common cold comes for us all—often more than once a year. And there is no way to prevent it. The best you can do is take vitamin C and stay away from people with the sniffles. Now, the payment company Stripe, founded by brothers Patrick and John Collison, says it will fund a new…

Brain-computer interface trials are taking off

This week, I covered the story of Casey Harrell—a man with ALS who is “the first power user” of a brain implant, according to the researchers who worked with him. Harrell is paralyzed and unable to speak coherently without the device. He has now spent almost three years using a brain-computer interface (BCI) that enables…

Geoengineering still faces major practical challenges

Solar geoengineering is often portrayed as a sort of emergency brake. Something along the lines of Pull in case of climate emergency to scatter light-reflecting particles to bounce sunlight out of the atmosphere and cool the planet. But it might be less like a simple brake and more like a complicated, entirely unsolved puzzle. Some…

This man with ALS is “the first power user” of a brain implant that lets him speak

Casey Harrell has had a set of electrodes embedded in his brain for almost three years. Harrell, who has amyotrophic lateral sclerosis (ALS) and is paralyzed, first used his brain-computer interface (BCI) to “speak” sentences with the help of a research team in 2023. Since then, Harrell has clocked thousands of hours of use. He…

Why “reprogramming” is the buzziest approach to reversing aging right now
Why “reprogramming” is the buzziest approach to reversing aging right now

Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…

Why China is betting on big nuclear reactors

It’s a tale of two nuclear industries. In China, large reactors are coming together at a stunning pace. The country has nearly doubled its nuclear fleet since 2016, reaching nearly 60 gigawatts of total power capacity. The new facilities are nearly all gigawatt-scale pressurized-water reactors. Meanwhile, the US has built just two reactors in that…

David Sinclair plans to test whole-body rejuvenation drugs in the XPrize competition

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a prescription that will make you 10 years younger. Now MIT Technology Review has learned that he has plans to launch human tests of an oral “reprogramming” drug as part of a $101 million competition organized…

Are AI chatbots making us lose control of our brains?

This week I’ve been at SXSW London. There’s been music, film, and a lot—and I mean a lot—of talk about AI. I also had the opportunity to sit down with Gloria Mark, a psychologist at the University of California, Irvine, who has spent the last 30 years studying how people interact with digital technologies. Early…

The Meta hack shows there’s more to AI security than Mythos

On June 5, 404 Media reported that attackers had been using Meta’s AI customer support agent to steal Instagram accounts. Their approach was simple: They asked the agent to link the accounts to email addresses that they controlled, and the agent complied. One attacker broke into the dormant Obama White House account and made pro-Iran…

How courts are coping with a flood of AI-generated lawsuits

Most days in her chambers, Judge Maritza Braswell, a federal magistrate judge in Colorado, sifts through stacks of documents written by people without a lawyer. Many of them can’t afford to hire a lawyer, and others have cases too weak or too small to interest one. She reads each one carefully, mindful of how daunting…